This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
General Mills (GIS) to Buy Tyson Foods' Pet Treats Business
by Zacks Equity Research
General Mills' (GIS) to acquire Tyson Foods' pet treats business by first-quarter fiscal 2022. The acquisition is in tandem with its Accelerate strategy.
B&G Foods (BGS) Q1 Earnings Miss Estimates, Sales Rise Y/Y
by Zacks Equity Research
B&G Foods (BGS) first-quarter fiscal 2021 results reflect higher earnings and sales on contribution from Crisco acquisition as well as persistent strength in base business net sales.
4 Must-Buy Efficient Stocks to Enrich Your Portfolio
by Tirthankar Chakraborty
Crocs (CROX), MEDIFAST (MED), Golden Entertainment (GDEN) and Herbalife (HLF) are the top companies that at present have favorable efficiency level and thus are expected to provide stellar returns.
Inter Parfums (IPAR) Q1 Earnings Top Estimates, Increase Y/Y
by Zacks Equity Research
Inter Parfums' (IPAR) first-quarter 2021 results reflect strong top and bottom lines. Solid performances in regions where lockdowns have been eased benefit results.
Coty (COTY) Q3 Earnings Match Estimates, Revenues Decline Y/Y
by Vrishali Bagree
Coty's (COTY) third-quarter fiscal 2021 results reflect lower revenues due to the pandemic-related woes, especially in Western Europe. However, cost-saving actions aid the bottom line.
Tyson Foods (TSN) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Tyson Foods' (TSN) second-quarter 2021 sales and earnings rise year over year on revenue growth across all segments. However, inflation across supply chain is a headwind.
Looking for Consumer Staples Stocks? The Zacks Rank Can Help You Find Winners
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
TreeHouse Foods (THS) Q1 Earnings Top Estimates, Sales Miss
by Zacks Equity Research
TreeHouse Foods' (THS) first-quarter 2021 results reflect lower retail demand due to tough year-over-year comparisons and inflationary pressure.
Hain Celestial (HAIN) Q3 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Hain Celestial's (HAIN) Q3 earnings reflect gains from improved margin performance and lower effective tax rate. It witnesses strong adjusted gross and EBITDA margin growth in the reported quarter
Post Holdings (POST) Q2 Earnings Miss, Sales Beat Estimates
by Zacks Equity Research
Post Holdings' (POST) Q2 results reflect declines in the Post Consumer Brands and Foodservice businesses. Also, comparison with last year's increased pantry-loading due to the pandemic hurt results.
The Zacks Analyst Blog Highlights: The Andersons, ArcBest Corp, RentACenter, Medifast and Gray Television
by Zacks Equity Research
The Zacks Analyst Blog Highlights: The Andersons, ArcBest Corp, RentACenter, Medifast and Gray Television
Grab These 5 Quality Stocks Screened on DuPont Analysis
by Sanghamitra Saha
Bet on five top-ranked stocks with higher ROE derived the DuPont way.
5 Mid-Cap Stocks That Reported Solid Q1 Results
by Sejuti Banerjea
Diversify your portfolio to include some mid-cap stocks.
Kellogg (K) Q1 Earnings & Sales Top Estimates, Guidance Raised
by Zacks Equity Research
Kellogg's (K) first-quarter 2021 results reflect solid earnings and sales growth, along with a raised guidance for 2021. Strength in the retail business continues to aid.
Nu Skin (NUS) Stock Gains on Q1 Earnings Beat & Raised View
by Zacks Equity Research
Nu Skin's (NUS) first-quarter 2021 earnings and revenues increase year over year on growth in sales leaders and customer base. Also, management raises 2021 view.
Medifast (MED) Moves 12.1% Higher: Will This Strength Last?
by Zacks Equity Research
Medifast (MED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
3 Reasons Why Medifast (MED) Is a Great Growth Stock
by Zacks Equity Research
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
Medifast (MED) Stock Gains on Q1 Earnings & Revenue Beat
by Zacks Equity Research
Medifast's (MED) first-quarter 2021 results reflect robust earnings and sales growth. The company continued to gain on solid OPTAVIA performance, courtesy of a rise in active earning coaches.
Medifast (MED) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 27.21% and 18.71%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
ADM (ADM) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
ADM (ADM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
If You Invested $1000 in Medifast a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Kellogg (K) Lined Up for Q1 Earnings: Key Factors to Watch
by Zacks Equity Research
Kellogg's (K) first-quarter 2021 results are likely to reflect softness in the foodservice business due to weak away-from-home food demand, though at-home consumption is likely to benefit the retail business.
Nu Skin (NUS) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Efforts to strengthen sales leader and expand customer base along with benefits from product innovations are likely to get reflected in Nu Skin's (NUS) first-quarter 2021 performance.
Keurig Dr Pepper (KDP) Q1 Earnings Beat Estimates, Sales Up
by Zacks Equity Research
Keurig Dr Pepper's (KDP) first-quarter performance reflects growth across all business segments, particularly in Coffee Systems. Moreover, management raises sales view for 2021.
Clorox (CLX) Q3 Earnings Beat & Sales Miss, FY21 View Updated
by Zacks Equity Research
Clorox's (CLX) third-quarter fiscal 2021 earnings beat estimates but declined year over year on lower gross margins and increased advertising investments.